anti-TRAIL-R3 (human), mAb (HS301)

AdipoGen Life Sciences

anti-TRAIL-R3 (human), mAb (HS301)

10

Recognizes human TRAIL-R3. Does not cross-react with human TRAIL-R1, -R2 or -R4.

Flow Cytometry, ImmunoCytoChemistry

Research Use Only

Monoclonal

HS301

1 mg/ml

>95%

Liquid

TNFRSF10C

TNF receptor superfamily member 10c

antagonist decoy receptor for TRAIL/Apo-2L; CD263; cytotoxic TRAIL receptor-3; DCR1; DCR1-TNFR; decoy receptor 1; decoy TRAIL receptor without death domain; LIT; lymphocyte inhibitor of TRAIL; TNF-related apoptosis-inducing ligand receptor 3; TRAILR3; TRAIL-R3; TRID; tumor necrosis factor receptor superfamily member 10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain

Mouse

IgG1

Tumor necrosis factor receptor superfamily member 10C

Monoclonal Antibody. Recognizes human TRAIL-R3. Does not cross-react with human TRAIL-R1, -R2 or -R4. Isotype: Mouse IgG1. Clone: HS301. Applications: FACS, ICC. Liquid. In PBS containing 10% glycerol and 0.02% sodium azide. TRAIL-R3 is a receptor for the cytotoxic ligand TRAIL. It lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. Protects cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand. - TRAIL-R3 is a receptor for the cytotoxic ligand TRAIL. It lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. Protects cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand.

Human

-20°C,2°C to 8°C

12352203